Detalhe da pesquisa
1.
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
Ann Oncol
; 30(5): 757-765, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865223
2.
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.
Ann Oncol
; 29(8): 1814-1821, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945238
3.
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.
Nat Commun
; 10(1): 3407, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431620
4.
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
Oncogene
; 26(5): 774-80, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16964294
5.
EZH2 alterations in follicular lymphoma: biological and clinical correlations.
Blood Cancer J
; 7(4): e555, 2017 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430172
6.
15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
FEBS Lett
; 501(1): 24-30, 2001 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-11457450